Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma

Published:2022-06 Issue:2 Volume:2 Page:98-105
ISSN:2667-0054
Container-title:Journal of the National Cancer Center
language:en
Short-container-title:Journal of the National Cancer Center

Author:

Wang Zhen,Chen Xiankai,Li Yong,Qin Jianjun,Fang Yuan,Yang Zhaoyang,Fang Yan,Qu Dong,Zhang Ruixiang,Zheng Qingfeng,Kang Xiaozheng,Xue Liyan,Huang Jing,Li Yin,He Jie^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. Cancer incidence and mortality in China, 2015;Zhang;Journal of the National Cancer Center,2021

3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

4. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial;Yang;J Clin Oncol,2018

5. Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma;Wong;J Gastrointest Surg,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial;Nature Medicine;2024-07-02

2. Development of perioperative immune checkpoint inhibitor therapy for locally advanced esophageal squamous cell carcinoma;Future Oncology;2024-05-17

3. Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial;eClinicalMedicine;2024-05

4. Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings;Cancers;2024-01-11

5. The Evolving Landscape of Neoadjuvant Immunotherapy in Gastroesophageal Cancer;Cancers;2024-01-09